<a href="https://laohu8.com/S/CTEV">Claritev Corporation</a> Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Growth of 3.5%, Significant Reduction in Net Loss from $576.7M to $62.6M
Claritev Corporation, a technology, data, and insights company, has announced its financial results for the second quarter of 2025. The company reported revenues of $241.6 million, marking a 3.5% increase compared to the $233.5 million in revenues for the same period in 2024. Claritev also reported a net loss of $62.6 million for Q2 2025, a significant improvement from the net loss of $576.7 million in Q2 2024. The adjusted EBITDA for Q2 2025 was $154.0 million, up from $146.7 million in the prior year. Claritev's updated outlook for the full year 2025 projects revenues to be flat to a 2% increase from FY 2024. The company maintained its adjusted EBITDA margin guidance of 62.5% to 63.5%. Capital expenditures are expected to rise, with revised guidance increasing from $155 million-$165 million to $170 million-$180 million. The effective tax rate guidance remains unchanged at 25% to 28%. Free cash flow guidance has been updated from a negative range of $(75) million to $(65) million to a range of $(20) million to $20 million. Claritev's President and CEO, Travis Dalton, emphasized the company's commitment to making healthcare more affordable and transparent, with a focus on driving results across expanded markets. The company has seen success with renewals, new deals, and partnerships in key areas.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250806936017) on August 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.